Back to JPMorgan Chase & Co. JPMorgan Chase & Co.

OACC

5 quarters

Position history for JPMorgan Chase & Co.JPMorgan Chase & Co.'s holdings in Oaktree Acquisition Corp. III Life Sciences

Yes. JPMorgan Chase holds 49,932 shares of OACC (Oaktree Acquisition Corp. III Life Sciences), worth $534,772, as of its Q2 2026 13F filing. It increased the position by 2 shares from Q1 2026. JPMorgan Chase has held OACC since Q2 2025, across 5 quarterly 13F filings.

Current Value

$534,772

Current Shares

49,932

Total Value Change

-$1.6M

Total Shares Change

-149,844

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
49,932
0.0%
$534,7720.0%$10.70
16
2026-Q1
Increased
49,930
+0.1%
$528,2590.0%$10.58
16
2025-Q4
Decreased
49,894
-33.3%
$530,3730.0%$10.58
0
2025-Q3
Decreased
74,817
-62.5%
$783,3340.0%$10.51
0
2025-Q2
New
199,776
-
$2.1M0.0%$10.45
36

Other major holders of OACC: Toronto-Dominion Bank, D. E. Shaw & Co., Inc., Driehaus Capital Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used